Home/Filings/4/0001104659-22-063797
4//SEC Filing

GREEN DAVID 4

Accession 0001104659-22-063797

CIK 0001563665other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 2:45 PM ET

Size

8.3 KB

Accession

0001104659-22-063797

Insider Transaction Report

Form 4
Period: 2022-05-12
GREEN DAVID
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-05-12$5.92/sh+63,345$375,002158,861 total
  • Purchase

    Warrants (right to buy)

    2022-05-12+31,67331,673 total
    Exercise: $8.88From: 2022-05-12Exp: 2027-05-12Common Stock (31,673 underlying)
Holdings
  • Common Stock

    (indirect: 2018 Biostage GRAT)
    16,468
Footnotes (1)
  • [F1]On May 12, 2022, the Issuer and the Reporting Person entered into 2 securities purchase agreements (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 63,345 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 31,673 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreements was $375,000.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1
  • filerCIK 0001008643

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 2:45 PM ET
Size
8.3 KB